Clinical Study
The Safety and Tolerability of 5-Aminolevulinic Acid Phosphate with Sodium Ferrous Citrate in Patients with Type 2 Diabetes Mellitus in Bahrain
Figure 3
Changes in mean HbA1c during dosing period ((a) ITT population, (b) PP population).
(a) |
(b) |